德克萨斯大学健康科学中心休斯顿分校(UTHealth Houston)的研究团队在医学期刊《神经病学》上发表了一项新研究,显示65岁以上老年人接种高剂量流感疫苗与阿尔茨海默病发病风险降低近55%存在关联 1。该结论基于对近20万名65岁及以上成年人数据的分析得出 1。研究主要作者包括共同通讯作者 Avram Samuel Bukhbinder 和资深作者 Paul Schulz 1。
此次发现的高剂量疫苗保护效果,优于此前研究证实的标准剂量流感疫苗所关联的40%风险降低率 1。美国疾病控制与预防中心(CDC)推荐65岁以上成人使用高剂量流感疫苗,其抗原含量是标准剂量的四倍 1。值得注意的是,研究指出这种关联性在女性群体中表现得尤为显著 1。研究团队强调,目前观察到的仅为相关性,尚未确立因果关系 1。
Researchers from the University of Texas Health Science Center at Houston (UTHealth Houston) have published a study in the medical journal Neurology linking high-dose influenza vaccination to a lower risk of Alzheimer’s disease among adults aged 65 and older 1. The analysis of data from nearly 200,000 individuals found that receiving the high-dose vaccine was associated with a nearly 55% reduction in the risk of developing Alzheimer’s 1. This protective association is stronger than previous findings for standard-dose vaccines, which had been linked to a 40% reduction in risk 1.
The high-dose vaccine contains four times the antigen content of the standard formulation and is currently recommended by the Centers for Disease Control and Prevention (CDC) for adults over 65 1. The study authors emphasized that these findings demonstrate correlation rather than causation 1. Additionally, the research indicated that women appeared to benefit more significantly from this association than men 1. Avram Samuel Bukhbinder served as co-corresponding author, and Paul Schulz was the senior author of the study 1.
评论
还没有评论,欢迎留下第一条。